Benitec Biopharma Income Statement (2019-2025) | BNTC

Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Shares Outstanding (Entity) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating items
Research & Development (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.01B0.01B0.00B0.00B0.01B
Selling, General & Administrative (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B
Other Operating Expenses (Quarter)
0.00B0.00B0.00B-0.00B0.00B-0.00B
Operating Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.01B0.01B0.00B0.01B0.01B0.01B0.02B0.01B0.01B0.01B
Operating Income (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B
EBIT (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B
Non-operating items
Non Operating Investment Income (Quarter)
-0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B
Other Non Operating Income (Quarter)
-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B
Non Operating Income (Quarter)
-0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Net income details
EBT (Quarter)
-0.00B-0.00B-0.01B-0.00B-0.00B-0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.36B-2.35B-4.86B-10.42B-12.18B-0.01B-17.38B-0.03B
Profit After Tax (Quarter)
-0.00B-0.00B-0.01B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.02B-0.01B-0.01B0.00B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B-0.00B
Income from Continuing Operations (Quarter)
-0.00B-0.00B-0.01B-0.00B-0.00B-0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.36B-2.35B-4.86B-10.42B-12.18B-0.01B-17.38B-0.03B
Consolidated Net Income (Quarter)
-0.00B-0.00B-0.01B-0.00B-0.00B-0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.36B-2.35B-4.86B-10.42B-12.18B-0.01B-17.38B-0.03B
Income towards Parent Company (Quarter)
-0.00B-0.00B-0.01B-0.00B-0.00B-0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.36B-2.35B-4.86B-10.42B-12.18B-0.01B-17.38B-0.03B
Net Income towards Common Stockholders (Quarter)
-0.00B-0.00B-0.01B-0.00B-0.00B-0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.00B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Additional items
EPS (Basic) (Quarter)
-13.61-16.02-10.51-10.38-7.49-47.23-8.43-3.91-3.55-11.86-3.05-2.64-1.64-1.16-0.48-0.43-0.38-0.24-0.22-0.26
EPS (Diluted) (Quarter)
-16.02-10.51-10.38-7.49-47.23-8.43-3.91-3.55-11.86-3.05-2.64-1.64-1.16-0.48-0.43-0.38-0.24-0.22-0.26
Shares Outstanding (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.02B0.04B0.04B0.04B0.05B
Shares Outstanding (Diluted) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.02B0.04B0.04B0.04B0.05B
EBITDA (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.02B0.00B0.00B0.00B0.01B0.00B0.01B0.35B2.34B4.86B10.41B12.16B0.00B17.37B0.01B